On or around 10/16/2019 (Notice of voluntarily dismissal)
Filing Date: September 25, 2019
According to the Complaint, Chardan is a special purpose acquisition company formed for the purpose of effecting a merger, acquisition, or similar business combination.
On July 16, 2019, Chardan’s Board of Directors caused Chardan to enter into an agreement and plan of merger with BiomX Ltd. Pursuant to the terms of the Merger Agreement, BiomX’s securityholders will receive an aggregate of 16,625,000 Chardan shares. As a result of the Proposed Transaction, Chardan’s public stockholders will only own approximately 20% of Chardan’s stock.
On September 13, 2019, Defendants filed a proxy statement with the United States Securities and Exchange Commission, which recommends that Chardan’s stockholders vote to approve the Proposed Transaction at a special meeting of stockholders scheduled for October 23, 2019. The Complaint alleges that the Proxy Statement omits material information with respect to the Proposed Transaction, which renders the Proxy Statement false and misleading.
This case was voluntarily dismissed as moot on October 16, 2019.
Company & Securities Information
Defendant: Chardan Healthcare Acquisition Corp.
Headquarters: United States
Ticker Symbol: CHAC
Company Market: New York SE
Market Status: Public (Listed)
About the Company & Securities Data
"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.
In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
First Identified Complaint
Jordan Rosenblatt, et al. v. Chardan Healthcare Acquisition Corp., et al.
COURT: D. Delaware
DOCKET #: 19-CV-01801
JUDGE: Hon. Colm F. Connolly
DATE FILED: 09/25/2019
CLASS PERIOD START: 07/17/2019
CLASS PERIOD END: 09/25/2019
PLAINTIFF FIRMS NAMED IN COMPLAINT:
Rigrodsky & Long, P.A. (Wilmington)
RM Law, P.C. (Berwyn)
First Identified Complaint (FIC) Filings:
Complaint for Violation of the Securities Exchange Act of 1934
U.S. District Court Civil Docket
Stipulation and [Proposed] Order of Dismissal
—Reference Complaint Complaint Related Data is not available
Related District Court Filings
—Related District Court Filings Data is not available